Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
380 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00110955 | Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy | completed | Phase 3 | 391 | AmgenINDUSTRY | 0 | Jan 15, 2010 | clinicaltrials |
| NCT00537667 | The SPECTRA Study | terminated | Phase 2 | 22 | AmgenINDUSTRY | 0 | Nov 26, 2009 | clinicaltrials |
| NCT00327119 |
| completed |
| Phase 2 |
| 50 |
| AmgenINDUSTRY |
| 0 |
| Sep 14, 2009 |
| clinicaltrials |
| NCT00117897 | Treatment for Subjects With Non-Hodgkin's Lymphoma | completed | Phase 2 | — | AmgenINDUSTRY | 0 | Jul 20, 2009 | clinicaltrials |
| NCT00091806 | Two Dose Schedules of Panitumumab in Subjects With Advanced Solid Tumors | completed | Phase 1 | 86 | AmgenINDUSTRY | 0 | Jul 10, 2009 | clinicaltrials |
| NCT00036023 | Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies | completed | Phase 2 | — | AmgenINDUSTRY | 0 | May 11, 2009 | clinicaltrials |
| NCT00115167 | A Study of Darbepoetin Alfa in Anemic Subjects Not Receiving Chemotherapy Who Have Completed the 20010103 Study | completed | Phase 3 | 371 | AmgenINDUSTRY | 0 | May 11, 2009 | clinicaltrials |
| NCT00119600 | A Study of AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy | terminated | Phase 1 / Phase 2 | — | AmgenINDUSTRY | 0 | May 11, 2009 | clinicaltrials |
| NCT00115206 | Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy | completed | Phase 4 | — | AmgenINDUSTRY | 0 | Apr 6, 2009 | clinicaltrials |
| NCT00117117 | A Study to Assess Symptom Burden in Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Aranesp® | completed | Phase 4 | 2,423 | AmgenINDUSTRY | 0 | Mar 25, 2009 | clinicaltrials |
| NCT00120705 | Treatment for Anemic Subjects With Non-Myeloid Malignancies Receiving Chemotherapy | completed | Phase 2 | 204 | AmgenINDUSTRY | 0 | Mar 25, 2009 | clinicaltrials |
| NCT00095277 | Darbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects With Anemia of Cancer | completed | Phase 2 | 220 | AmgenINDUSTRY | 0 | Mar 13, 2009 | clinicaltrials |
| NCT00094822 | Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC) | completed | — | 90 | AmgenINDUSTRY | 0 | Feb 13, 2009 | clinicaltrials |
| NCT00113789 | Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects With Relapsed or Refractory Ovarian Cancer | completed | Phase 2 | 21 | AmgenINDUSTRY | 0 | Feb 13, 2009 | clinicaltrials |
| NCT00114764 | Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML) | completed | Phase 2 | 84 | AmgenINDUSTRY | 0 | Oct 31, 2008 | clinicaltrials |
| NCT00117039 | A Study to Evaluate the Effectiveness of Aranesp® for Cancer Patients With Anemia | completed | Phase 4 | 1,500 | AmgenINDUSTRY | 0 | Oct 15, 2008 | clinicaltrials |
| NCT00038064 | Anemia in Patients With a Non-Myeloid Malignancy | completed | Phase 3 | 707 | AmgenINDUSTRY | 0 | Sep 15, 2008 | clinicaltrials |
| NCT00425204 | Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment | completed | Phase 2 | 31 | AmgenINDUSTRY | 0 | Sep 15, 2008 | clinicaltrials |
| NCT00115414 | Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC) | completed | Phase 2 | — | AmgenINDUSTRY | 0 | Aug 1, 2008 | clinicaltrials |
| NCT00117910 | Treatment for Elderly Patients With High Risk Breast Cancer | completed | Phase 3 | — | AmgenINDUSTRY | 0 | May 16, 2008 | clinicaltrials |
| NCT00066092 | Pegfilgrastim PBPC Mobilization Study | completed | Phase 2 | 41 | AmgenINDUSTRY | 0 | Feb 28, 2008 | clinicaltrials |
| NCT00111137 | Treatment for Patients With Non-Myeloid Malignancies Receiving Chemotherapy | completed | Phase 3 | 718 | AmgenINDUSTRY | 0 | Feb 28, 2008 | clinicaltrials |
| NCT00044902 | Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade) | completed | Phase 2 | — | AmgenINDUSTRY | 0 | Dec 28, 2007 | clinicaltrials |
| NCT00117624 | A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With a Non-Myeloid Malignancy | completed | Phase 3 | — | AmgenINDUSTRY | 0 | Dec 28, 2007 | clinicaltrials |
| NCT00034346 | ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) | completed | Phase 2 | 194 | AmgenINDUSTRY | 0 | Dec 24, 2007 | clinicaltrials |
| NCT00120679 | Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy | completed | Phase 2 | — | AmgenINDUSTRY | 0 | Dec 24, 2007 | clinicaltrials |
| NCT00120692 | Treatment for Patients Suffering From Anemia Due to Chemotherapy | completed | Phase 2 | — | AmgenINDUSTRY | 0 | Dec 24, 2007 | clinicaltrials |
| NCT00121030 | Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy | completed | Phase 2 | — | AmgenINDUSTRY | 0 | Dec 24, 2007 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials